Michael berridge canterbury


My main research interest concerns the mode of action of hormones and neurotransmitters at the cellular level, with particular emphasis on the role of calcium as an intracellular second messenger. The problem is to understand how cells detect external signals and translate them into the change in ... Sir Michael John Berridge, FRS FMedSci FBPhS (born 22 October 1938) is a British physiologist and biochemist. Born and raised in Southern Rhodesia (today Zimbabwe), he is best known for his work on cellular transmembrane signalling , in particular the discovery that inositol trisphosphate acts as a second messenger , linking events at the plasma membrane with the release of Ca 2+ within the cell. [3] Just to quickly refresh your memory, dear reader, we are living in times of budget cuts and belt-tightening. There has been widespread local coverage of Canterbury City Council slashing, cutting, trimming and salami slicing. In the expectation that their central funding will be reduced, CCC has been wielding the knife on all but the biggest ... Oct 17, 2016 · Sir Michael John Berridge, FRS FMedSci FBPhS (born 22 October 1938) is a Rhodesian-born British physiologist and biochemist. He is best known for his work on cellular transmembrane signalling, in particular the discovery that inositol trisphosphate acts as a second messenger, linking events at the plasma membrane with the release of Ca2+ within the cell. CANTERBURY CT4 5NA 01227 830 260 [email protected] . Tony Austin Con: Sturry North: The Purlins Black Robin Lane Kingston CANTERBURY CT4 6HR 01227 830 131 [email protected] . Michael Berridge LibDem: St Stephens: 3 Birch Road CANTERBURY CT1 3BS 01227 470 027 [email protected] . Jo Calvert-Mindell ... May 14, 2013 · Prof Michael Eccles, of the University of Otago, has gained $150,000 in Health Research Council funding to undertake world-first research into a new way to measure the aggressiveness of cancer cells. If successful, the project could revolutionise techniques used for cancer cell detection and cancer diagnosis.